Table 1.
Baseline clinical and procedural characteristics of the study population.
| N=65355 | |
|---|---|
| Clinical characteristic | |
| Age (mean ± SD) | 76.2 ± 8.1 |
| Female sex (n, %) | 27008 (41.3%) |
| LV dysfunction (n, %) | 8274 (12.7%) |
| Hypertension (n, %) | 60182 (92.1%) |
| Diabetes mellitus (n, %) | 24554 (37.6%) |
| Renal dysfunction (n, %) | 9150 (14.0%) |
| Hepatic dysfunction (n, %) | 2077 (3.2%) |
| CHA2DS2VASc score (mean ± SD) | 4.6±1.5 |
| HAS-BLED score (mean ± SD) | 3.0 ± 1.1 |
| Clinically relevant prior bleeding | 44292 (67.9%) |
| AF classification, paroxysmal (n, %) | 35894 (54.9%) |
| Body mass index (mean ± SD) | 30.1 ± 10.4 |
| Platelet count (mean ± SD) | 208358 ± 71558 |
| Albumin (mean ± SD) | 3.84 ± 0.5 |
| Creatinine (mean ± SD) | 1.3 ± 1.1 |
| INR (mean ± SD) | 1.41 ± 1.0 |
| Hemoglobin (mean ± SD) | 12.7 ± 2.1 |
| Procedural characteristic | |
| Number of devices used per case (mean ± SD) | 1.2 ± 0.6 |
| Multiple delivery sheaths used | 2977 (4.6%) |
| Largest device size attempted (median) | 27mm |
| General anesthesia (N, %) | 63812 (97.6%) |
AF, atrial fibrillation; INR, international normalized ratio, SD standard deviation.